Creating a Global Policy Strategy to Support the Launch of an Innovative Influenza Antiviral for a Top-5 Pharma Company

The global headquarters of a top-5 pharmaceutical company needed to develop a global policy strategy to support the launch of a new treatment for influenza.

Shift Health reviewed the literature and conducted interviews with subject matter experts and client colleagues to identify policy challenges of relevance to the antiviral business strategy. Shift Health reflected on findings from the research and developed a draft policy strategy outlining an overarching challenge, goals and enablers, and prioritizing the stakeholders to engage to create a favourable policy environment. Our team facilitated an in-person workshop with the client team to review, validate and refine the policy strategy.

Fully endorsed by the client, the policy strategy served as a central reference for policy initiatives at the global and affiliate level to prime the market for the introduction of the novel antiviral treatment.